Position in ARGX
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$597,344
+$31,385 QoQ
Shares Held
818
+21.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aaron Wealth Advisors LLC holds $41,772,254 across 14 Biotechnology names. ARGX ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MBX |
MBX Biosciences, Inc.
|
1,168,176 | $34,870,053 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,042 | $2,251,454 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,102 | $851,449 | |
| 4 | ARGX |
Argenx SE
This page
|
818 | $597,344 | |
| 5 | MNKD |
Mannkind Corp
|
235,652 | $577,347 | |
| 6 | KURA |
Kura Oncology, Inc.
|
66,840 | $543,409 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
2,524 | $477,162 | |
| 8 | RPRX |
Royalty Pharma plc
|
9,254 | $443,914 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $597,344 | 818 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $565,959 | 673 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $361,404 | 490 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $304,273 | 552 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $298,891 | 505 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $300,735 | 489 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $240,683 | 444 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||